Los Angeles Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Buy |
5,149
+2,553
| +98% | +$773K | 0.01% | 505 |
|
|
2025
Q1 | $860K | Sell |
2,596
-156
| -6% | -$51.7K | ﹤0.01% | 604 |
|
|
2024
Q4 | $849K | Buy |
+2,752
| New | +$849K | ﹤0.01% | 670 |
|
|
2023
Q2 | – | Sell |
-1,029
| Closed | -$249K | – | 1234 |
|
|
2023
Q1 | $249K | Buy |
+1,029
| New | +$249K | ﹤0.01% | 1072 |
|
|
2021
Q2 | – | Sell |
-6,260
| Closed | -$732K | – | 1619 |
|
|
2021
Q1 | $732K | Sell |
6,260
-5,202
| -45% | -$608K | ﹤0.01% | 1049 |
|
|
2020
Q4 | $1.27M | Buy |
11,462
+125
| +1% | +$13.9K | 0.01% | 828 |
|
|
2020
Q3 | $1.35M | Sell |
11,337
-1,660
| -13% | -$197K | 0.01% | 702 |
|
|
2020
Q2 | $1.47M | Buy |
12,997
+255
| +2% | +$28.9K | 0.01% | 711 |
|
|
2020
Q1 | $851K | Buy |
+12,742
| New | +$851K | 0.01% | 754 |
|
|
2019
Q3 | – | Sell |
-2,053
| Closed | -$215K | – | 1323 |
|
|
2019
Q2 | $215K | Buy |
+2,053
| New | +$215K | ﹤0.01% | 1279 |
|